Market Closed -
Japan Exchange
11:30:00 10/05/2024 am IST
|
5-day change
|
1st Jan Change
|
167
JPY
|
-0.60%
|
|
+0.60%
|
-12.11%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
3,590
|
3,191
|
2,728
|
2,832
|
1,830
|
1,928
|
Enterprise Value (EV)
1 |
3,200
|
3,273
|
2,761
|
3,431
|
2,501
|
2,323
|
P/E ratio
|
13.5
x
|
-21.8
x
|
-6.17
x
|
-7.89
x
|
914
x
|
35.6
x
|
Yield
|
0.85%
|
0.96%
|
1.14%
|
-
|
-
|
-
|
Capitalization / Revenue
|
1.03
x
|
1.13
x
|
1.12
x
|
0.9
x
|
0.39
x
|
0.43
x
|
EV / Revenue
|
0.92
x
|
1.16
x
|
1.14
x
|
1.09
x
|
0.54
x
|
0.52
x
|
EV / EBITDA
|
11.7
x
|
20.5
x
|
-11.8
x
|
-51.2
x
|
16.8
x
|
12.2
x
|
EV / FCF
|
-
|
-1,25,93,400
x
|
1,43,80,433
x
|
-66,41,864
x
|
-1,72,34,241
x
|
1,98,32,482
x
|
FCF Yield
|
-
|
-0%
|
0%
|
-0%
|
-0%
|
0%
|
Price to Book
|
1.8
x
|
1.74
x
|
1.99
x
|
1.96
x
|
1.4
x
|
1.33
x
|
Nbr of stocks (in thousands)
|
8,756
|
8,790
|
8,886
|
9,767
|
9,787
|
10,147
|
Reference price
2 |
410.0
|
363.0
|
307.0
|
290.0
|
187.0
|
190.0
|
Announcement Date
|
27/03/19
|
26/03/20
|
30/03/21
|
30/03/22
|
30/03/23
|
29/03/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
3,479
|
2,833
|
2,426
|
3,158
|
4,671
|
4,497
|
EBITDA
1 |
274
|
160
|
-233
|
-67
|
149
|
191
|
EBIT
1 |
155
|
25
|
-410
|
-223
|
3
|
51
|
Operating Margin
|
4.46%
|
0.88%
|
-16.9%
|
-7.06%
|
0.06%
|
1.13%
|
Earnings before Tax (EBT)
1 |
602
|
-63
|
-410
|
-332
|
26
|
72
|
Net income
1 |
269
|
-146
|
-440
|
-351
|
2
|
53
|
Net margin
|
7.73%
|
-5.15%
|
-18.14%
|
-11.11%
|
0.04%
|
1.18%
|
EPS
2 |
30.39
|
-16.63
|
-49.78
|
-36.74
|
0.2047
|
5.335
|
Free Cash Flow
|
-
|
-259.9
|
192
|
-516.6
|
-145.1
|
117.1
|
FCF margin
|
-
|
-9.17%
|
7.91%
|
-16.36%
|
-3.11%
|
2.6%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
61.32%
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
220.99%
|
Dividend per Share
2 |
3.500
|
3.500
|
3.500
|
-
|
-
|
-
|
Announcement Date
|
27/03/19
|
26/03/20
|
30/03/21
|
30/03/22
|
30/03/23
|
29/03/24
|
Fiscal Period: December |
2020 S1
|
2021 S1
|
2021 Q3
|
2022 Q1
|
2022 S1
|
2022 Q3
|
2023 Q1
|
2023 S1
|
2023 Q3
|
---|
Net sales
1 |
1,186
|
1,340
|
682
|
1,091
|
2,169
|
1,215
|
1,021
|
2,108
|
1,034
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
-111
|
-34
|
-100
|
-25
|
-13
|
16
|
-68
|
-65
|
12
|
Operating Margin
|
-9.36%
|
-2.54%
|
-14.66%
|
-2.29%
|
-0.6%
|
1.32%
|
-6.66%
|
-3.08%
|
1.16%
|
Earnings before Tax (EBT)
1 |
-90
|
-2
|
-109
|
-25
|
-10
|
23
|
-59
|
-56
|
-5
|
Net income
1 |
-97
|
-12
|
-114
|
-32
|
-25
|
14
|
-69
|
-71
|
-13
|
Net margin
|
-8.18%
|
-0.9%
|
-16.72%
|
-2.93%
|
-1.15%
|
1.15%
|
-6.76%
|
-3.37%
|
-1.26%
|
EPS
2 |
-11.13
|
-1.360
|
-11.95
|
-3.360
|
-2.630
|
1.420
|
-7.080
|
-7.310
|
-1.250
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
07/08/20
|
06/08/21
|
11/11/21
|
12/05/22
|
10/08/22
|
11/11/22
|
12/05/23
|
09/08/23
|
13/11/23
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
82
|
33
|
599
|
671
|
395
|
Net Cash position
1 |
390
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
0.5125
x
|
-0.1416
x
|
-8.94
x
|
4.503
x
|
2.068
x
|
Free Cash Flow
|
-
|
-260
|
192
|
-517
|
-145
|
117
|
ROE (net income / shareholders' equity)
|
-
|
-7.61%
|
-27.4%
|
-25%
|
0.15%
|
3.85%
|
ROA (Net income/ Total Assets)
|
-
|
0.35%
|
-5.91%
|
-2.81%
|
0.04%
|
0.69%
|
Assets
1 |
-
|
-41,185
|
7,439
|
12,513
|
5,479
|
7,669
|
Book Value Per Share
2 |
228.0
|
209.0
|
154.0
|
148.0
|
133.0
|
142.0
|
Cash Flow per Share
2 |
170.0
|
155.0
|
193.0
|
188.0
|
126.0
|
112.0
|
Capex
1 |
92
|
47
|
18
|
33
|
105
|
75
|
Capex / Sales
|
2.64%
|
1.66%
|
0.74%
|
1.04%
|
2.25%
|
1.67%
|
Announcement Date
|
27/03/19
|
26/03/20
|
30/03/21
|
30/03/22
|
30/03/23
|
29/03/24
|
|
1st Jan change
|
Capi.
|
---|
| -12.11% | 10.87M | | +20.68% | 85.55B | | -29.31% | 70.07B | | +9.65% | 29.06B | | -8.63% | 17.51B | | +2.14% | 17.39B | | +0.39% | 15.38B | | +6.47% | 13.4B | | +68.09% | 12.87B | | +6.43% | 12.77B |
Other Healthcare Facilities & Services
|